
IRIDEX Corporation IRIX
$ 0.7
-2.78%
IRIDEX Corporation ROCE Ratio | IRIX
Annual ROCE Ratio IRIDEX Corporation
| 2026 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -52.23 | -395.9 | -105.09 | -43.77 | -37.91 | - | -35.85 | -41.28 | -41.24 | 0.84 | 7.44 | - | 10.0 | -3.82 | 13.97 | 8.18 | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.97 | -395.9 | -51.19 |
Quarterly ROCE Ratio IRIDEX Corporation
| 2026-Q4 | 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -81.82 | -97.33 | -76.57 | -141.01 | -173.0 | -208.24 | -184.18 | -198.17 | -148.39 | -101.02 | -50.27 | -59.64 | -56.77 | -45.93 | -31.17 | -39.69 | -34.54 | -30.61 | -19.93 | -30.63 | -36.92 | -40.51 | -33.33 | -41.49 | -41.66 | -40.22 | -32.4 | -42.62 | -45.41 | -46.61 | -33.24 | -50.34 | -50.18 | -48.21 | -42.23 | -27.88 | -21.0 | -13.03 | -6.55 | -3.37 | -2.37 | -0.22 | -0.6 | 1.76 | 2.88 | 7.32 | 6.17 | 8.74 | 8.37 | 10.28 | 8.03 | 5.39 | 1.22 | -1.85 | -5.32 | -4.19 | -0.48 | 2.28 | 3.35 | 1.12 | 1.07 | 1.16 |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 10.28 | -208.24 | -39.55 |
ROCE Ratio of other stocks in the Medical devices industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abbott Laboratories
ABT
|
15.45 | $ 110.59 | 0.07 % | $ 193 B | ||
|
EDAP TMS S.A.
EDAP
|
-42.56 | - | - | $ 162 M | ||
|
Align Technology
ALGN
|
12.65 | $ 174.54 | 0.16 % | $ 12.7 B | ||
|
TELA Bio
TELA
|
-53.21 | $ 0.83 | -4.37 % | $ 39 M | ||
|
Edwards Lifesciences Corporation
EW
|
10.64 | $ 104.0 | -0.68 % | $ 60.8 B | ||
|
Avinger
AVGR
|
268.22 | - | -20.74 % | $ 369 K | ||
|
CONMED Corporation
CNMD
|
5.1 | $ 51.21 | -1.42 % | $ 1.59 B | ||
|
Medtronic PLC
MDT
|
13.07 | $ 101.59 | -1.17 % | $ 130 B | ||
|
MiMedx Group
MDXG
|
22.95 | $ 3.37 | 1.36 % | $ 498 M | ||
|
ThermoGenesis Holdings
THMO
|
516.5 | - | -25.84 % | $ 171 K | ||
|
Talis Biomedical Corporation
TLIS
|
-96.67 | - | 3.55 % | $ 7.96 M | ||
|
Myomo
MYO
|
-47.54 | $ 1.32 | -5.71 % | $ 55.2 M | ||
|
Insulet Corporation
PODD
|
18.87 | $ 148.03 | -1.19 % | $ 10.4 B | ||
|
Profound Medical Corp.
PROF
|
-57.78 | $ 7.66 | 4.36 % | $ 232 M | ||
|
Quanterix Corporation
QTRX
|
-36.49 | $ 3.3 | -2.51 % | $ 141 M | ||
|
Viveve Medical
VIVE
|
-143.06 | - | -15.35 % | $ 1.71 M | ||
|
Smith & Nephew plc
SNN
|
8.96 | $ 30.96 | -0.29 % | $ 26.8 B | ||
|
Sensus Healthcare
SRTS
|
-21.43 | $ 3.42 | 7.39 % | $ 55.8 M | ||
|
Stryker Corporation
SYK
|
21.81 | $ 324.18 | -0.48 % | $ 124 B | ||
|
Tactile Systems Technology
TCMD
|
12.57 | $ 26.61 | 0.08 % | $ 609 M | ||
|
TransMedics Group
TMDX
|
11.09 | $ 91.02 | -2.95 % | $ 3.09 B | ||
|
SmileDirectClub
SDC
|
68.05 | - | -53.45 % | $ 9.71 M | ||
|
Viemed Healthcare
VMD
|
14.7 | $ 9.04 | 1.01 % | $ 352 M | ||
|
Varex Imaging Corporation
VREX
|
-5.88 | $ 18.45 | 0.03 % | $ 764 M | ||
|
Acutus Medical
AFIB
|
0.49 | - | -26.83 % | $ 2.62 M | ||
|
Vivos Therapeutics
VVOS
|
1335.17 | $ 0.09 | -8.14 % | $ 925 K | ||
|
BIOLASE
BIOL
|
7261.94 | - | -13.19 % | $ 166 K | ||
|
SeaSpine Holdings Corporation
SPNE
|
-19.52 | - | 0.28 % | $ 270 M | ||
|
Xtant Medical Holdings
XTNT
|
14.3 | $ 0.28 | -0.68 % | $ 39.1 M | ||
|
Zimmer Biomet Holdings
ZBH
|
5.36 | $ 107.39 | -0.87 % | $ 21.3 B | ||
|
Apollo Endosurgery
APEN
|
-96.4 | - | - | $ 475 M | ||
|
NuVasive
NUVA
|
7.21 | - | - | $ 2.07 B | ||
|
Nano-X Imaging Ltd.
NNOX
|
-53.85 | $ 0.37 | 59.63 % | $ 24 M | ||
|
Penumbra
PEN
|
11.52 | $ 321.48 | -0.11 % | $ 12.5 B | ||
|
Conformis
CFMS
|
-85.42 | - | - | $ 16.4 M | ||
|
ViewRay
VRAY
|
-130.26 | - | 1.54 % | $ 468 M | ||
|
Medigus Ltd.
MDGS
|
-37.78 | - | 10.28 % | $ 55.5 M | ||
|
Boston Scientific Corporation
BSX
|
14.91 | $ 44.68 | 1.49 % | $ 66.1 B | ||
|
Cutera
CUTR
|
-60.43 | - | -10.19 % | $ 1.99 M | ||
|
Neovasc
NVCN
|
-50.8 | - | - | $ 111 M | ||
|
Vapotherm
VAPO
|
70.63 | - | 6.72 % | $ 34 M | ||
|
Nevro Corp.
NVRO
|
-54.64 | - | - | $ 217 M | ||
|
Venus Concept
VERO
|
-72.63 | - | - | $ 726 K | ||
|
Eargo
EAR
|
-110.81 | - | - | $ 10.2 M | ||
|
Sientra
SIEN
|
16882.64 | - | -16.59 % | $ 10.3 M | ||
|
Silk Road Medical, Inc
SILK
|
-39.21 | - | - | $ 1.07 B | ||
|
Surgalign Holdings
SRGA
|
304.96 | - | -32.98 % | $ 1.68 M | ||
|
Cardiovascular Systems
CSII
|
-14.35 | - | 0.15 % | $ 844 M | ||
|
ShockWave Medical
SWAV
|
23.79 | - | - | $ 12.3 B | ||
|
Inari Medical
NARI
|
-3.02 | - | - | $ 4.23 B |